{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:37:02Z","timestamp":1792121822893,"version":"4.4.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>We studied simultaneously Epstein\u2013Barr virus (EBV)-specific CD4+ and CD8+ T cell responses during and after infectious mononucleosis (IM), using a previously described 12-day stimulation protocol with EBNA1 or BZLF1 peptide pools. Effector function of EBV-specific T cells was determined after restimulation by measuring intracellular interferon-\u03b3 production. During IM, BZLF1-specifc CD4+ T cell responses were dominant compared with CD8+ T cell responses. EBNA1-specific CD4+ and CD8+ T cell responses were low and remained similar for 6 months. However, 6 months after IM, BZLF1-specific CD4+ T cell responses had declined, but CD8+ T cell responses had increased. At diagnosis, EBV-specific CD8+ T cells as studied by human leucocyte antigen class I tetramer staining comprised a tetramerbrightCD8bright population consisting mainly of CD27+ memory T cells and a tetramerdimCD8dim population consisting primarily of CD27- effector T cells. The remaining EBV-specific CD8+ T cell population 6 months after the diagnosis of IM consisted mainly of tetramerbrightCD8brightCD27+ T cells, suggesting preferential preservation of memory T cells after contraction of the EBV-specific T cell pool.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03699.x","type":"journal-article","created":{"date-parts":[[2008,10,12]],"date-time":"2008-10-12T21:06:48Z","timestamp":1223845608000},"page":"231-239","source":"Crossref","is-referenced-by-count":50,"title":["Detailed analysis of Epstein\u2013Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis"],"prefix":"10.1093","volume":"153","author":[{"given":"J","family":"Scherrenburg","sequence":"first","affiliation":[{"name":"Department of Immunology, University Medical Center Utrecht, Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R W A N","family":"Piriou","sequence":"additional","affiliation":[{"name":"Department of Clinical Viro-Immunology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N M","family":"Nanlohy","sequence":"additional","affiliation":[{"name":"Department of Immunology, University Medical Center Utrecht, Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"van Baarle","sequence":"additional","affiliation":[{"name":"Department of Immunology, University Medical Center Utrecht, Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022010405133502400_b1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nat Med"},{"key":"2022010405133502400_b2","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.4049\/jimmunol.165.9.4831","article-title":"Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response","volume":"165","author":"Annels","year":"2000","journal-title":"J Immunol"},{"key":"2022010405133502400_b3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI10590","article-title":"CD8(+) T-cell selection, function, and death in the primary immune response in vivo","volume":"106","author":"Callan","year":"2000","journal-title":"J Clin Invest"},{"key":"2022010405133502400_b4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein\u2013Barr virus in vivo","volume":"187","author":"Callan","year":"1999","journal-title":"J Exp Med"},{"key":"2022010405133502400_b5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.20011692","article-title":"Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein\u2013Barr virus infection","volume":"195","author":"Hislop","year":"2002","journal-title":"J Exp Med"},{"key":"2022010405133502400_b6","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.163.10.5735","article-title":"Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection","volume":"163","author":"Hoshino","year":"1999","journal-title":"J Immunol"},{"key":"2022010405133502400_b7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/315737","article-title":"Changes in the composition of circulating CD8+ T cell subsets during acute Epstein\u2013Barr virus and human immunodeficiency virus infection in man","volume":"182","author":"Roos","year":"2000","journal-title":"J Infect Dis"},{"key":"2022010405133502400_b8","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.4049\/jimmunol.167.8.4450","article-title":"Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection","volume":"167","author":"Catalina","year":"2001","journal-title":"J Immunol"},{"key":"2022010405133502400_b9","first-page":"379","volume-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","author":"Appay","year":"2002"},{"key":"2022010405133502400_b10","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.4049\/jimmunol.170.5.2590","article-title":"Differential kinetics and specificity of EBV-specific CD4(+) and CD8(+) T cells during primary infection","volume":"170","author":"Precopio","year":"2003","journal-title":"J Immunol"},{"key":"2022010405133502400_b11","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/491741","article-title":"Differential targeting and shifts in the immunodominance of Epstein\u2013Barr virus-specific CD8 and CD4 T cell responses during acute and persistent infection","volume":"192","author":"Woodberry","year":"2005","journal-title":"J Infect Dis"},{"key":"2022010405133502400_b12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/eji.200425792","article-title":"Novel method for detection of virus-specific CD4(+) T cells indicates a decreased EBV-specific CD4(+) T cell response in untreated HIV-infected subjects","volume":"35","author":"Piriou","year":"2005","journal-title":"Eur J Immunol"},{"key":"2022010405133502400_b13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/CVI.00250-06","article-title":"CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells","volume":"14","author":"Hoji","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"2022010405133502400_b14","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.4049\/jimmunol.172.11.6931","article-title":"Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma","volume":"172","author":"Piriou","year":"2004","journal-title":"J Immunol"},{"key":"2022010405133502400_b15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200210180-00004","article-title":"Lack of Epstein\u2013Barr virus- and HIV-specific CD27\u2013 CD8+ T cells is associated with progression to viral disease in HIV-infection","volume":"16","author":"Van Baarle","year":"2002","journal-title":"AIDS"},{"key":"2022010405133502400_b16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1128\/jvi.61.7.2063-2070.1987","article-title":"The 160,000-Mr virion protein encoded at the right end of the herpesvirus saimiri genome is homologous to the 140,000-Mr membrane antigen encoded at the left end of the Epstein\u2013Barr virus genome","volume":"61","author":"Cameron","year":"1987","journal-title":"J Virol"},{"key":"2022010405133502400_b17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.38.2.712-715.2000","article-title":"The development of a high-throughput real-time quantitative assay for Epstein\u2013Barr virus detection","volume":"38","author":"Niesters","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2022010405133502400_b18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/341460","article-title":"Absolute level of Epstein\u2013Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma","volume":"186","author":"Van Baarle","year":"2002","journal-title":"J Infect Dis"},{"key":"2022010405133502400_b19","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","article-title":"Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes","volume":"12","author":"Pongers-Willemse","year":"1998","journal-title":"Leukemia"},{"key":"2022010405133502400_b20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M","article-title":"High viral burden in the presence of major HIV-specific CD8+ T cell expansions: evidence for impaired T cell effector function","volume":"31","author":"Kostense","year":"2001","journal-title":"Eur J Immunol"},{"key":"2022010405133502400_b21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1073\/pnas.2237267100","article-title":"Demonstration of the Burkitt's lymphoma Epstein\u2013Barr virus phenotype in dividing latently infected memory cells in vivo","volume":"101","author":"Hochberg","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405133502400_b22","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/516513","article-title":"Dominant cytotoxic T lymphocyte response to the immediate\u2013early trans-activator protein, BZLF1, in persistent type A or B Epstein\u2013Barr virus infection","volume":"176","author":"Elliott","year":"1997","journal-title":"J Infect Dis"},{"key":"2022010405133502400_b23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clim.2005.11.009","article-title":"Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient","volume":"119","author":"Piriou","year":"2006","journal-title":"Clin Immunol"},{"key":"2022010405133502400_b24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1182\/blood-2006-05-023663","article-title":"Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein\u2013Barr virus nuclear antigen 1 in healthy virus carriers","volume":"109","author":"Heller","year":"2007","journal-title":"Blood"},{"key":"2022010405133502400_b25","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1128\/JVI.75.18.8649-8659.2001","article-title":"Differential immunogenicity of Epstein\u2013Barr virus latent-cycle proteins for human CD4+ T-helper responses","volume":"75","author":"Leen","year":"2001","journal-title":"J Virol"},{"key":"2022010405133502400_b26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.191.10.1649","article-title":"Human CD4(+) T lymphocytes consistently respond to the latent Epstein\u2013Barr virus nuclear antigen EBNA1","volume":"191","author":"Munz","year":"2000","journal-title":"J Exp Med"},{"key":"2022010405133502400_b27","first-page":"2575","volume-title":"Virology","author":"Rickinson","year":"2001"},{"key":"2022010405133502400_b28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm1009","article-title":"A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease","volume":"10","author":"Reece","year":"2004","journal-title":"Nat Med"},{"key":"2022010405133502400_b29","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein\u2013Barr virus nuclear antigen 1","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405133502400_b30","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","article-title":"The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1","volume":"165","author":"Blake","year":"2000","journal-title":"J Immunol"},{"key":"2022010405133502400_b31","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20040121","article-title":"CD8 T cell recognition of endogenously expressed Epstein\u2013Barr virus nuclear antigen 1","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"2022010405133502400_b32","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.175.3.2010","article-title":"Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy","volume":"175","author":"Piriou","year":"2005","journal-title":"J Immunol"},{"key":"2022010405133502400_b33","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2005-01-0432","article-title":"Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma","volume":"106","author":"Piriou","year":"2005","journal-title":"Blood"},{"key":"2022010405133502400_b34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20031219","article-title":"Evidence for the presentation of major histocompatibility complex class I-restricted Epstein\u2013Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes","volume":"199","author":"Voo","year":"2004","journal-title":"J Exp Med"},{"key":"2022010405133502400_b35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/088282403763635401","article-title":"The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein\u2013Barr virus","volume":"16","author":"Callan","year":"2003","journal-title":"Viral Immunol"},{"key":"2022010405133502400_b36","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.4049\/jimmunol.174.9.5332","article-title":"Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection","volume":"174","author":"Lawrence","year":"2005","journal-title":"J Immunol"},{"key":"2022010405133502400_b37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol"},{"key":"2022010405133502400_b38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20022058","article-title":"Characterization of the CD4+ T cell responses to Epstein\u2013Barr virus during primary and persistent infection","volume":"198","author":"Amyes","year":"2003","journal-title":"J Exp Med"},{"key":"2022010405133502400_b39","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI24810","article-title":"Tonsillar homing of Epstein\u2013Barr virus-specific CD8+ T cells and the virus\u2013host balance","volume":"115","author":"Hislop","year":"2005","journal-title":"J Clin Invest"},{"key":"2022010405133502400_b40","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.4049\/jimmunol.175.7.4355","article-title":"AlphaEbeta7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population","volume":"175","author":"Woodberry","year":"2005","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03699.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03699.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/153\/2\/231\/42040997\/j.1365-2249.2008.03699.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/153\/2\/231\/42040997\/j.1365-2249.2008.03699.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T10:18:32Z","timestamp":1709288312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/153\/2\/231\/6457507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,7,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03699.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,8]]},"published":{"date-parts":[[2008,6,28]]}}}